↓ Skip to main content

Colchicine for Prevention of Postpericardiotomy Syndrome and Postoperative Atrial Fibrillation: The COPPS-2 Randomized Clinical Trial

Overview of attention for article published in JAMA: Journal of the American Medical Association, September 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
11 news outlets
blogs
2 blogs
policy
1 policy source
twitter
30 X users
peer_reviews
1 peer review site
weibo
1 weibo user
facebook
1 Facebook page
wikipedia
1 Wikipedia page
googleplus
1 Google+ user

Citations

dimensions_citation
276 Dimensions

Readers on

mendeley
262 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Colchicine for Prevention of Postpericardiotomy Syndrome and Postoperative Atrial Fibrillation: The COPPS-2 Randomized Clinical Trial
Published in
JAMA: Journal of the American Medical Association, September 2014
DOI 10.1001/jama.2014.11026
Pubmed ID
Authors

Massimo Imazio, Antonio Brucato, Paolo Ferrazzi, Alberto Pullara, Yehuda Adler, Alberto Barosi, Alida L. Caforio, Roberto Cemin, Fabio Chirillo, Chiara Comoglio, Diego Cugola, Davide Cumetti, Oleksandr Dyrda, Stefania Ferrua, Yaron Finkelstein, Roberto Flocco, Anna Gandino, Brian Hoit, Francesco Innocente, Silvia Maestroni, Francesco Musumeci, Jae Oh, Amedeo Pergolini, Vincenzo Polizzi, Arsen Ristić, Caterina Simon, David H Spodick, Vincenzo Tarzia, Stefania Trimboli, Anna Valenti, Riccardo Belli, Fiorenzo Gaita

Abstract

Postpericardiotomy syndrome, postoperative atrial fibrillation (AF), and postoperative effusions may be responsible for increased morbidity and health care costs after cardiac surgery. Postoperative use of colchicine prevented these complications in a single trial.

X Demographics

X Demographics

The data shown below were collected from the profiles of 30 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 262 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 <1%
Brazil 1 <1%
United Kingdom 1 <1%
Bosnia and Herzegovina 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 256 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 43 16%
Other 36 14%
Student > Postgraduate 26 10%
Student > Master 23 9%
Student > Ph. D. Student 16 6%
Other 56 21%
Unknown 62 24%
Readers by discipline Count As %
Medicine and Dentistry 141 54%
Nursing and Health Professions 8 3%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Agricultural and Biological Sciences 6 2%
Biochemistry, Genetics and Molecular Biology 6 2%
Other 18 7%
Unknown 76 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 113. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2021.
All research outputs
#376,882
of 26,017,215 outputs
Outputs from JAMA: Journal of the American Medical Association
#4,443
of 36,846 outputs
Outputs of similar age
#3,415
of 253,785 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#57
of 372 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,846 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 72.6. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,785 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 372 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.